Patent ID: 11938217
Assignee: SLAYBACK PHARMA LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. A stable ready-to-use injectable pharmaceutical composition for reversing effects of non-depolarizing neuromuscular blocking agents in a patient in need thereof, comprising:
(i) about 1 mg/mL of neostigmine or a pharmaceutically acceptable salt, solvate or hydrate thereof,
(ii) about 0.2 mg/mL of glycopyrrolate or a pharmaceutically acceptable salt, solvate or hydrate thereof,
(iii) a pharmaceutically acceptable liquid vehicle,
wherein the pharmaceutical composition has a pH ranging from 3.0 to 4.0,
wherein the level of Neostigmine Impurity A in the composition is less than 1% when stored at 40° C. for at least 3 months.